The global breast cancer imaging market size was valued USD 3.6 billion in 2020 and is anticipated to register at a robust CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the improved quality of breast images, patient comfort, and reduced patient dose.
Request Free Sample Report Here
Breast cancer imaging system is a diagnostic tool utilized for locating the site of cancer cells. It provides detailed information such as extent of the disease as well as the structural changes. Cancer imaging systems detect the tumor in the body and its associated complications, which helps in the evaluation of the post therapeutic treatment by specialists.
Breast cancer imaging is also used to evaluate the stages. Mammography, ultrasonography, and breast magnetic resonance imaging (MRI) are three types of imaging systems that are used for detection of breast cancer.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing technological advancements in the field of breast imaging and rising investment from different organizations for breast cancer screening campaigns are projected to boost the market growth.
- Patient is exposed to multiple sets of radiations for therapeutic purposes during breast imaging procedures, which can create challenges for the growth of the market.
- Growing awareness about screening programs is speculated to stimulate the market growth.
- Rising adoption of advanced mammography devices with innovative technologies is estimated to drive the market growth in the coming years.
- Extensive adoption of artificial intelligence (AI) and machine learning (ML) to improve patient quality of life, which is expected to push the market growth.
Breast Cancer Imaging Market Segment Insights
Mammography segment to constitute a large market share
Based on types of imaging techniques, the market is divided into mammography, breast ultrasound, breast MRI, image-guided breast biopsy, and others. The mammography segment is expected to represent a major market share during the forecast period. Rising initiatives taken to increase the awareness about the breast cancer is expected to propel the market growth. Mammography is the standard technique used to screen breast cancer in government and private healthcare hospitals. Government state bodies across the globe are taking initiatives to provide treatment for women between the age 50 and 75, spurring the segment growth.
Hospitals segment to expand a substantial CAGR
In terms of end-users, the market is segmented into hospitals, diagnostic centers, and others. The hospitals segment is anticipated to register a substantial CAGR during the forecast period. Increasing healthcare infrastructure development, higher purchasing power, and availability of well-equipped operating & diagnostic rooms, and better health coverage for healthcare services are expected to proliferate the segment growth.
North America to dominate the market
On the basis of regions, the market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to the growing burden of breast cancer coupled with advancement in healthcare infrastructure and rising healthcare expenditure.
Compititive Landscape
Key players competing in the breast cancer imaging market include General Medical Merate S.p.A., Aurora Health Care, CMR Naviscan Corporation, SonoCine, Inc., and Dilon Technologies, Inc.
About Growth Market Reports:
GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GROWTH MARKET REPORTS has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.
Contact:
Growth Market Reports
Phone: +1 909 414 1393
Email: [email protected]
Web: https://growthmarketreports.com
Breast Imaging Technologies Market growth is largely driven by factors such as technological advancements, the rising prevalence of breast cancer, the increasing number of screening programs as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis.The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.What the Breast Imaging Market Looks Like?Predicted to grow at a CAGR of 8.0% during the forecast period, the global Breast Imaging Market is estimated to reach USD 4.6 Billion by the end of 2023.
In 2018, North America to dominate the breast imaging market during the forecast period.Based on technology, the market is segmented into ionizing (mammography, PET-CT, MBI, and PEM) and non-ionizing (breast ultrasound, breast MRI, AWBU, and breast thermography), and other breast imaging technologies (CBCT, electrical impedance tomography, and optical imaging).The ionizing breast imaging technology segment accounted for the largest share of the breast imaging market during the forecast period.
The large share of this market segment is primarily due to the technological advancements in ionizing breast imaging technologies and rising awareness about the early screening and diagnosis of breast cancer.Based on type, the mammography market is classified into full-field digital mammography, 3D breast tomosynthesis, and analog mammography.
The 3D breast tomosynthesis segment is expected to witness the highest CAGR during the forecast period.The growing demand for advanced screening technologies and increasing regulatory approvals for 3D breast tomosynthesis systems are the key factors driving the growth of this segment.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897What Drives the Breast Imaging Market?The growth of the global market for Breast Imaging is primarily influenced by the following factors:Growing Incidence of Breast CancerIncreasing Public-Private Investments, Funds, and GrantsIncreasing Awareness on Early Detection of Breast CancerGrowth in the Aging PopulationGeographical growth scenario of Breast Imaging MarketGeographically, the Breast Imaging market has been studied for North America, Europe, Asia Pacific, and the Rest of the World.
The North American region accounted for the largest share of the breast imaging market in 2018.The rising incidence of breast cancer, easy accessibility and high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure in the US and Canada), and the rapidly increasing geriatric population in the region are some of the major factors driving the growth of the breast imaging market in North America.Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=897Leading market players and strategies adoptedThe prominent players in the Breast Imaging market include Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), FUJIFILM Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCiné, Inc. (US), and SuperSonic Imagine (France).
